Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trials
Introduction: Multiple sclerosis (MS) is the most common inflammatory disease of the central nervous system (CNS). Demyelination, the main pathology in MS, contributes to clinical symptoms and long-term neurological deficits if left untreated. Remyelination, the natural repair of damaged myelin by c...
Saved in:
Main Authors: | , , , |
---|---|
Other Authors: | |
Format: | Review |
Published: |
2022
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/78693 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|